The Importance of Integrating Sickle Cell Disease and Thalassemia Screening in Pre-Conception Health Care
|A CONFERENCE SPONSORED BY|
|Office of the Regional Health Administrator
Office of Family Planning
Office of Minority Health
Office on Women’s Health
Cicatelli Associates, Title X Regional Training Center
Clinical Directors Network, Inc.
New Jersey Family Planning League
New York University College of Nursing
|To Download the Conference Brochure, Please CLICK HERE.
Why is this issue important?
Sickle Cell Disease (SCD) and Thalassemia present unique challenges to individuals, families and heath care providers. As inherited blood diseases with no cure, individuals living with SCD or Thalassemia face numerous challenges throughout their life span – serious health complications, fragmented services, limited access to comprehensive heath care services, socioeconomic and discrimination. SCD and Thalassemia have not been recognized as a priority for public health despite many years of research and advancement in treatment approaches.What has been done?
In the past 100 years since James Herrick’s first description of SCD in the United States, there has been gradual progress in management of the disease. Newborn screening for SCD and Thalassemia are mandated nationally and positive cases are referred for follow-up care. Over the years the US Department of Health and Human Services has supported research and programs addressing genetic disorders. Most recently one of the Family Planning Program Priorities emphasizes the importance of counseling family planning clients on establishing a reproductive life plan, and providing preconception counseling as a part of family planning services, as appropriate. However, much need to be done in reaching out and educating immigrant populations unaware of their genetic disorders; counseling individuals with traits.
What is the meeting’s goal?
The goal of the meeting is to raise the awareness of SCD and Thalassemia, for which public health issues remain real challenges for individuals and families. The learning objectives are to explore issues related to SCD and Thalassemia, screening and counseling during pre-conception, practices in clinical care, and strategies for enhanced health service delivery to better support individuals and families in disease management. The meeting will conclude with a call to action for improved public health education, increased screening and counseling, and more coordinated and sustained care in order to recognize SCD and Thalassemia as a public health priority.Target Audience
The target audience is professionals working in family planning and primary health care, minority health, women’s health, pediatrics, and related fields. Those working in health promotion and disease prevention, as well as in care and treatment are invited to attend. These may include: physicians, physician assistants, nurses, nurse-midwives, health educators, genetic counselors, social workers, dietitians and other primary health care providers.
|26 Federal Plaza
New York. NY 10278
|Friday, December 10, 2010 8:15 AM – 3:00 PM EST|
|9:15 AM Welcome & Overview
April Velasco, PhD
Acting Regional Health Administrator
US Department of Health and Human Services – Region II9:30 AM Pre-Conception Care: Every Woman, Every Time
Peter Bernstein, MD, MPH
Professor of Clinical Obstetrics & Gynecology – Women’s Health
Director of the Fellowship Program in Maternal Fetal Medicine
Montefiore Medical Center/Albert Einstein College of Medicine
10:00 AM Pre-Conception Care and Genetic Counseling
10:45 AM The Impact of Hemoglobinopathy Diseases on Individuals, Families and
2:15 PM Addressing Health Services for Thalassemia Clients
Beth Savage, MSN, CPNP, CPON
3:00 PM Call to Action/ Next Steps